Harmony Biosciences Holdings, Inc. HRMY Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Harmony Biosciences Holdings, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Harmony Biosciences Holdings, Inc.'s operating cash flow?
- Harmony Biosciences Holdings, Inc. (HRMY) reported operating cash flow of $27.76M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s operating cash flow changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s operating cash flow decreased by 18.3% year-over-year, from $33.99M to $27.76M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s operating cash flow has grown at a 37.1% compound annual growth rate (CAGR), from $98.56M to $348.2M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.